Medline Inc. Class A Common Stock (MDLN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medline Inc. Class A Common Stock (MDLN) has a cash flow conversion efficiency ratio of 0.012x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($229.00 Million) by net assets ($19.29 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medline Inc. Class A Common Stock - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Medline Inc. Class A Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Medline Inc. Class A Common Stock balance sheet liabilities for a breakdown of total debt and financial obligations.
Medline Inc. Class A Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medline Inc. Class A Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PG&E Corp
NYSE:PCG
|
0.060x |
|
Naspers Limited
F:NNWN
|
N/A |
|
Crown Castle
NYSE:CCI
|
-1.870x |
|
Commerzbank AG
XETRA:CBK
|
0.068x |
|
Keysight Technologies Inc
NYSE:KEYS
|
0.038x |
|
Interactive Brokers Group Inc
NASDAQ:IBKR
|
0.079x |
|
CHINA PAC.IN.GR.GDR/5 YC1
F:75CB
|
N/A |
|
EMCOR Group Inc
NYSE:EME
|
0.143x |
Annual Cash Flow Conversion Efficiency for Medline Inc. Class A Common Stock (2023–2025)
The table below shows the annual cash flow conversion efficiency of Medline Inc. Class A Common Stock from 2023 to 2025. For the full company profile with market capitalisation and key ratios, see MDLN company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $19.29 Billion | $1.74 Billion | 0.090x | -15.53% |
| 2024-12-31 | $16.52 Billion | $1.77 Billion | 0.107x | +7.86% |
| 2023-12-31 | $16.98 Billion | $1.69 Billion | 0.099x | -- |
About Medline Inc. Class A Common Stock
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front … Read more